{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T22:38:39Z","timestamp":1766011119202},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuro-Oncol"],"published-print":{"date-parts":[[1993]]},"DOI":"10.1007\/bf01057041","type":"journal-article","created":{"date-parts":[[2005,1,31]],"date-time":"2005-01-31T18:20:04Z","timestamp":1107195604000},"page":"243-272","source":"Crossref","is-referenced-by-count":39,"title":["Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy"],"prefix":"10.1007","volume":"16","author":[{"given":"Dennis F.","family":"Deen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Chiarodo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Fike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence E.","family":"Kun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor A.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence J.","family":"Marton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger J.","family":"Packer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony E.","family":"Pegg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L.","family":"Rosenblum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman D.","family":"Suit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol J.","family":"Wikstrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles B.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert J.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. K. Alfred","family":"Yung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/1097-0142(19830401)51:7<1209::AID-CNCR2820510707>3.0.CO;2-J","volume":"51","author":"VT DeVita","year":"1983","unstructured":"DeVita VT: The relationship between tumor mass and resistance to chemotherapy: implications for surgical adjuvant treatment of cancer. Cancer 51: 1209?1220, 1983","journal-title":"Cancer"},{"key":"CR2","first-page":"81","volume":"70","author":"DP Griswold Jr","year":"1986","unstructured":"Griswold DP Jr: Body burden of cancer in relationship to therapeutic outcome: consideration of preclinical evidence. Cancer Treat Rep 70: 81?86, 1986","journal-title":"Cancer Treat Rep"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1227\/00006123-198711000-00001","volume":"21","author":"M Ammirati","year":"1987","unstructured":"Ammirati M, Galicich JH, Arbit Eet al.: Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 21: 607?614, 1987","journal-title":"Neurosurgery"},{"key":"CR4","first-page":"739","volume":"70","author":"VA Levin","year":"1986","unstructured":"Levin VA, Wara WM, Davis RLet al.: Northern California Oncology Group Protocol 6G91: response to treatment with radiation therapy and seven-drug chemotherapy in patients with glioblastoma multiforme. Cancer Treat Rep 70: 739?743, 1986","journal-title":"Cancer Treat Rep"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/jns.1989.71.1.0001","volume":"71","author":"WR Shapiro","year":"1989","unstructured":"Shapiro WR, Green SB, Burger PC, Mahaley MS Jr, Selker RG, VanGilder JC, Robertson JT, Ransohoff J, Mealey J Jr, Strike TA, Pistenmaa DA: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71: 1?9, 1989","journal-title":"J Neurosurg"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3171\/jns.1989.71.4.0487","volume":"71","author":"MJ Winger","year":"1989","unstructured":"Winger MJ, Macdonald DR, Cairncross JG: Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71: 487?493, 1989","journal-title":"J Neurosurg"},{"key":"CR7","first-page":"488","volume":"4","author":"J Andreou","year":"1983","unstructured":"Andreou J, George AE, Wise Aet al.: CT prognostic criteria of survival after malignant glioma surgery. AJNR Am J Neuroradiol 4: 488?490, 1983","journal-title":"AJNR Am J Neuroradiol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3171\/jns.1980.52.5.0642","volume":"52","author":"VA Levin","year":"1980","unstructured":"Levin VA, Hoffman WF, Heilbron DC, Norman D: Prognostic significance of the pretreatment CT scan on time to progression for patients with malignant gliomas. J Neurosurg 52: 642?647, 1980","journal-title":"J Neurosurg"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1200\/JCO.1988.6.2.338","volume":"6","author":"JR Wood","year":"1988","unstructured":"Wood JR, Green SB, Shapiro WR: The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 6: 338?343, 1988","journal-title":"J Clin Oncol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3171\/jns.1986.65.6.0799","volume":"65","author":"J Murovic","year":"1986","unstructured":"Murovic J, Turowski K, Wilson CB, Hoshino T, Levin V: Computerized tomography in the prognosis of malignant cerebral gliomas. J Neurosurg 65: 799?806, 1986","journal-title":"J Neurosurg"},{"key":"CR11","first-page":"32","volume":"38","author":"CB Wilson","year":"1992","unstructured":"Wilson CB: Glioblastoma the past, the present, and the future. Clin Neurosurg 38: 32?48, 1992","journal-title":"Clin Neurosurg"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0360-3016(90)90399-5","volume":"18","author":"GE Sheline","year":"1990","unstructured":"Sheline GE: Radiotherapy for high grade gliomas. Int J Radiat Oncol Biol Phys 18: 793?803, 1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0167-8140(87)80215-3","volume":"9","author":"H Keim","year":"1987","unstructured":"Keim H, Potthoff PC, Schmidt Ket al.: Survival and quality of life after continuous accelerated radiotherapy of glioblastomas. Radiother Oncol 9: 21?26, 1987","journal-title":"Radiother Oncol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0360-3016(92)90543-Q","volume":"23","author":"A Taghian","year":"1992","unstructured":"Taghian A, Suit H, Pardo Fet al.:In vitro intrinsic radiation sensitivity of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 23: 55?62, 1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3109\/02841869109088242","volume":"30","author":"GD Wilson","year":"1991","unstructured":"Wilson GD: Assessment of human tumour proliferation using bromodeoxyuridine ? current status. Acta Oncol1 30: 903?910, 1991","journal-title":"Acta Oncol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/1097-0142(19910501)67:9<2247::AID-CNCR2820670906>3.0.CO;2-Q","volume":"67","author":"G Shenouda","year":"1991","unstructured":"Shenouda G, Souhami L, Freeman CRet al.: Accelerated fractionation for high-grade cerebral astrocytomas. Preliminary treatment results. Cancer 67: 2247?2252, 1991","journal-title":"Cancer"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3171\/jns.1989.70.5.0691","volume":"70","author":"MSB Edwards","year":"1989","unstructured":"Edwards MSB, Wara WM, Urtasun RC, Prados M, Levin VA, Fulton D, Wilson CB, Hannigan J, Silver P: Hyperfractionated radiation therapy for brain-stem glioma: a phase I?II trial. J Neurosurg 70: 691?700, 1989","journal-title":"J Neurosurg"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0360-3016(98)90010-4","volume":"15","author":"CR Freeman","year":"1988","unstructured":"Freeman CR, Krischer J, Sanford RAet al.: Hyperfractionated radiotherapy in brain stem tumors: results of a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 15: 311?318, 1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/1097-0142(19910801)68:3<474::AID-CNCR2820680305>3.0.CO;2-7","volume":"68","author":"CR Freeman","year":"1991","unstructured":"Freeman CR, Krischer J, Sanford RAetal.: Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cGy dose level of Pediatric Oncology Group study #8495. Cancer 68: 474?481, 1991","journal-title":"Cancer"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ana.410270212","volume":"27","author":"RJ Packer","year":"1990","unstructured":"Packer RJ, Allen JC, Goldwein JLet al.: Hyperfractionated radiotherapy for children with brainstem gliomas: a pilot study using 7,200 cGy. Ann Neurol 27: 167?173, 1990","journal-title":"Ann Neurol"},{"key":"CR21","first-page":"263","volume":"12","author":"M Prados","year":"1992","unstructured":"Prados M, Edwards M, Wara Wet al.: Hyperfractionated radiotherapy in the management of patients with medulloblastoma (Abstract). J Neurooncol 12: 263, 1992","journal-title":"J Neurooncol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF00172458","volume":"12","author":"C Allen","year":"1992","unstructured":"Allen C, Nirenberg A, Donahue B: Hyperfractionated radiotherapy and adjuvant chemotherapy for high risk PNET (Abstract). J Neurooncol 12: 262, 1992","journal-title":"J Neurooncol"},{"key":"CR23","first-page":"112","volume":"16","author":"LE Kun","year":"1991","unstructured":"Kun LE, Fontanesi J, Kovnar Eet al.: Hyperfractionated craniospinal irradiation?A phase I trial in children with malignant central nervous system tumors. Pediatr Neurosurg 16: 112, 1991","journal-title":"Pediatr Neurosurg"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0360-3016(91)90004-N","volume":"20","author":"FE Halberg","year":"1991","unstructured":"Halberg FE, Wara WM, Fippin LFet al.: Low-dose craniospinal radiation therapy for medulloblastoma. Int J Radiat Oncol Biol Phys 20: 651?654, 1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0360-3016(91)90038-6","volume":"20","author":"LE Kun","year":"1991","unstructured":"Kun LE, Constine LS: Medulloblastoma ? caution regarding new treatment approaches (Editorial). Int J Radiat Oncol Biol Phys 20: 897?899, 1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0360-3016(91)90676-U","volume":"21","author":"PH Gutin","year":"1991","unstructured":"Gutin PH, Prados MD, Phillips TLet al.: External irradiation followed by an interstitial high activity iodine-125 implant ?boost? in the initial treatment of malignant gliomas. NCOG study 6G-82-2. Int J Radiat Oncol Biol Phys 21: 601?606, 1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0360-3016(89)90518-X","volume":"17","author":"SA Leibel","year":"1989","unstructured":"Leibel SA, Gutin PH, Wara WMet al.: Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 17: 1129?1139, 1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/jnci\/82.24.1918","volume":"82","author":"JS Loeffler","year":"1990","unstructured":"Loeffler JS, Alexander E 3d, When PYet al.: Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma. J Natl Cancer Inst 82: 1918?1921, 1990","journal-title":"J Natl Cancer Inst"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1542\/peds.85.5.774","volume":"85","author":"JS Loeffler","year":"1990","unstructured":"Loeffler JS, Rossitch E Jr, Siddon Ret al.: Role of stereotactic radiosurgery with a linear accelerator in treatment of intracranial arteriovenous malformation and tumors in children. Pediatrics 85: 774?782, 1990","journal-title":"Pediatrics"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archneur.1990.00530020071018","volume":"47","author":"LD Lunsford","year":"1990","unstructured":"Lunsford LD, Flickinger J, Coffey RJ: Stereotactic gamma knife radiosurgery. Initial North American experience in 207 patients. Arch Neurol 47: 169?175, 1990","journal-title":"Arch Neurol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiology.176.2.2195597","volume":"176","author":"JG Schwade","year":"1990","unstructured":"Schwade JG, Houdek PV, Landy HJet al.: Small-field stereotactic external-beam radiation therapy of intracranial lesions: fractionated treatment with a fixed-halo immobilization device. Radiology 176: 563?565, 1990","journal-title":"Radiology"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0360-3016(91)90169-5","volume":"21","author":"Photon Treatment Planning Collaborative Working Group","year":"1991","unstructured":"Photon Treatment Planning Collaborative Working Group: Three-dimensional display in planning radiation therapy: a clinical perspective. Int J Radiat Oncol Biol Phys 21: 79?89, 1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0360-3016(90)90551-T","volume":"19","author":"RG Evans","year":"1990","unstructured":"Evans RG, Kimler BF, Morantz RAet al.: A phase I\/II study of the use of Fluosol as an adjuvant to radiation therapy in the treatment of primary high-grade brain tumors. Int J Radiat Oncol Biol Phys 19: 415?420, 1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR34","first-page":"265","volume":"12","author":"BF Kimler","year":"1992","unstructured":"Kimler BF, Evans RG, Morantz RAet al.: Lack of long-term complications subsequent to the use of Fluosol and oxygen as adjuvant to radiation therapy for high-grade malignant brain tumors (Abstract). J Neurooncol 12: 265, 1992","journal-title":"J Neurooncol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3171\/jns.1991.75.4.0559","volume":"75","author":"BC Liang","year":"1991","unstructured":"Liang BC, Thornton AF Jr, Sandler HM, Greenberg HS: Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy. J Neurosurg 75: 559?563, 1991","journal-title":"J Neurosurg"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0360-3016(91)90690-6","volume":"21","author":"TL Phillips","year":"1991","unstructured":"Phillips TL, Levin VA, Ahn DKet al.: Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center phase II study. Int J Radiat Oncol Biol Phys 21: 709?714, 1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0360-3016(86)90071-4","volume":"12","author":"EP Malaise","year":"1986","unstructured":"Malaise EP, Fertil B, Chavaudra Net al.: Distribution of radiation sensitivities for human tumor cells of specific histological types: comparison ofin vitro toin vivo data. Int J Radiat Oncol Biol Phys 12: 617?624, 1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0167-8140(90)90202-8","volume":"17","author":"LJ Peters","year":"1990","unstructured":"Peters LJ: The ESTRO Regaud lecture. Inherent radiosensitivity of tumor and normal tissue cells as a predictor of human tumor response. Radiother Oncol 17: 177?190, 1990","journal-title":"Radiother Oncol"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/978-1-4613-3858-1_14","volume-title":"Oncology of the Nervous System","author":"DP Byar","year":"1983","unstructured":"Byar DP, Green SB, Strike TA: Prognostic factors for malignant glioma. In: Walker MD (ed) Oncology of the Nervous System, Martinus Nijhoff, Boston, 379?395, 1983"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3171\/jns.1990.72.4.0572","volume":"72","author":"AE Evans","year":"1990","unstructured":"Evans AE, Jenkin RDT, Sposto R, Ortega JA, Wilson CB, Wara W, Ertel IJ, Kramer S, Chang CH, Leikin SL, Hammond GD: The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72: 572?582, 1990","journal-title":"J Neurosurg"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3171\/jns.1984.60.5.0994","volume":"60","author":"PG Hughes","year":"1984","unstructured":"Hughes PG: Cerebellar medulloblastoma in adults. J Neurosurg 60: 994?997, 1984","journal-title":"J Neurosurg"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3171\/jns.1992.76.5.0772","volume":"76","author":"WR Shapiro","year":"1992","unstructured":"Shapiro WR, Green SB, Burger PC, Selker RG, VanGilder JC, Robertson JT, Mealey J Jr, Ransohoff J, Mahaley MS Jr: A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 76: 772?781, 1992","journal-title":"J Neurosurg"},{"key":"CR43","first-page":"241","volume":"12","author":"HJ Eyre","year":"1992","unstructured":"Eyre HJ, Jaeckle K, Green SJet al.: AZQ 24-hour infusion vs BCNU for adult high-grade gliomas: preliminary results of SWOG-8737 (Abstract). J Neurooncol 12: 241, 1992","journal-title":"J Neurooncol"},{"key":"CR44","first-page":"241","volume":"12","author":"C Schold","year":"1992","unstructured":"Schold C: Recent CNS Cancer Consortium trials with AZQ, mitomycin, 6-mercaptopurine, cyclophosphamide, and intracarotid cisplatin (Abstract). J Neurooncol 12: 241, 1992","journal-title":"J Neurooncol"},{"key":"CR45","first-page":"242","volume":"12","author":"J Buckner","year":"1992","unstructured":"Buckner J, Cascino T, Shaw Eet al.: Clinical trials in brain tumors: Mayo Clinic\/North Central Cancer Treatment Group (NCCTG) (Abstract). J Neurooncol 12: 242, 1992","journal-title":"J Neurooncol"},{"key":"CR46","first-page":"242","volume":"12","author":"KA Jaeckle","year":"1992","unstructured":"Jaeckle KA, Black KL, LaSala Pet al.: Phase II multicenter trial of serratia biologic response modifier (S-BRM) in recurrent malignant astrocytomas (MA) (Abstract). J Neurooncol 12: 242, 1992","journal-title":"J Neurooncol"},{"key":"CR47","first-page":"249","volume":"12","author":"P Duffner","year":"1992","unstructured":"Duffner P, Horowitz M, Krischer Jet al.: Postoperative chemotherapy and delayed RT in infants with brain tumors: a Pediatric Oncology Group study (Abstract). J Neurooncol 12: 249, 1992","journal-title":"J Neurooncol"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0360-3016(90)90096-3","volume":"18","author":"VA Levin","year":"1990","unstructured":"Levin VA, Silver P, Hannigan Jet al.: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18: 321?324, 1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR49","first-page":"91","volume":"9","author":"VA Levin","year":"1990","unstructured":"Levin VA, Wara WM, Gutin PHet al.: Initial analysis of NCOG 6G82-1: bromodeoxyuridine (BUdR) during irradiation followed by CCNU, procarbazine, and vincristine (PCV) chemotherapy for malignant gliomas (Abstract). Proc Am Soc Clin Oncol 9: 91, 1990","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1200\/JCO.1992.10.5.766","volume":"10","author":"VA Levin","year":"1992","unstructured":"Levin VA, Prados MD: Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance. J Clin Oncol 10: 766?771, 1992","journal-title":"J Clin Oncol"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1002\/1097-0142(19890615)63:12<2475::AID-CNCR2820631219>3.0.CO;2-H","volume":"63","author":"JM Rozental","year":"1989","unstructured":"Rozental JM, Robins HI, Finlay Jet al.: ?Eight-drugs-in-one-day?: chemotherapy administered before and after radiotherapy to adult patients with malignant gliomas. Cancer 63: 2475?2481, 1989","journal-title":"Cancer"},{"key":"CR52","first-page":"239","volume":"12","author":"A Finlay","year":"1992","unstructured":"Finlay A: An update on the brain tumor trials of the Children's Cancer Study Group (CCSG) (Abstract). J Neurooncol 12: 239, 1992","journal-title":"J Neurooncol"},{"key":"CR53","first-page":"239","volume":"12","author":"H Friedman","year":"1992","unstructured":"Friedman H, Kun LE, POG Brain Tumor Core Committee: Pediatric Oncology Group (POG) brain tumor progress report (Abstract). J Neurooncol 12: 239, 1992","journal-title":"J Neurooncol"},{"key":"CR54","first-page":"266","volume":"12","author":"C Kretschmar","year":"1992","unstructured":"Kretschmar C, Tarbell N, Barnes Pet al.: Pre-radiation chemotherapy (chemorx) for children with pontine gliomas (Abstract). J Neurooncol 12: 266, 1992","journal-title":"J Neurooncol"},{"key":"CR55","first-page":"240","volume":"12","author":"RJ Packer","year":"1992","unstructured":"Packer RJ: R\u00e9gional and NCI Working-Group trials in children with brain tumors (Abstract). J Neurooncol 12: 240, 1992","journal-title":"J Neurooncol"},{"key":"CR56","first-page":"124","volume":"10","author":"M Deutsch","year":"1991","unstructured":"Deutsch M, Thomas P, Boyette Jet al.: Low-stage medulloblastoma: a Children's Cancer Study Group (CCSG) and Pediatric Oncology Group (POG) randomized study of standard versus reduced neuro-axis irradiation (Abstract). Proc Am Soc Clin Oncol 10: 124, 1991","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR57","first-page":"240","volume":"12","author":"CC Bailey","year":"1992","unstructured":"Bailey CC, Gwentow AK, Michaelis Jet al.: SIOP II\/GPO Med.84 Medulloblastoma trial annual status report 1991 (Abstract). J Neurooncol 12: 240, 1992","journal-title":"J Neurooncol"},{"key":"CR58","first-page":"240","volume":"12","author":"J K\u00fchl","year":"1992","unstructured":"K\u00fchl J: Preliminary results of the German pilot trial hit 88\/89 in children and young adults with medulloblastoma (Abstract). J Neurooncol 12: 240, 1992","journal-title":"J Neurooncol"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jnci\/84.18.1432","volume":"84","author":"VA Levin","year":"1992","unstructured":"Levin VA, Prados MD, Yung WKAet al.: Treatment of recurrent gliomas with eflornithine. J Natl Cancer Inst 84: 1432?1437, 1992","journal-title":"J Natl Cancer Inst"},{"key":"CR60","first-page":"252","volume":"12","author":"EA Grimm","year":"1992","unstructured":"Grimm EA, List J, Loudon WGet al.: Cellular immune response in the human brain: cytokine cascade in the CSF after intraventricular IL-2 injection (Abstract). J Neurooncol 12: 252, 1992","journal-title":"J Neurooncol"},{"key":"CR61","first-page":"281","volume":"12","author":"S-I Miyatake","year":"1992","unstructured":"Miyatake S-I, Nishihara K, Kibuchi H: Efficient tumor suppression by glioma-specific murine cytotoxic T lymphocytes transfected with IFN-? gene (Abstract). J Neurooncol 12: 281, 1992","journal-title":"J Neurooncol"},{"key":"CR62","first-page":"268","volume":"12","author":"RP Moser","year":"1992","unstructured":"Moser RP, Gingras MC, Bruner JMet al.: Lymphocyte recruitment and trafficking in brain tumors (Abstract). J Neurooncol 12: 268, 1992","journal-title":"J Neurooncol"},{"issue":"Suppl","key":"CR63","first-page":"5074s","volume":"81","author":"SA Rosenberg","year":"1991","unstructured":"Rosenberg SA: Immunotherapy and gene therapy of cancer. Proc Am Assoc Cancer Res 81 (Suppl): 5074s-5079s, 1991","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR64","first-page":"281","volume":"12","author":"CD Rice","year":"1992","unstructured":"Rice CD, Merchant RE, Young HF: Recombinant interleukin-1? increases survival of rats with glioma by stimulating leukocytic infiltration and inhibiting angiogenesis (Abstract). J Neurooncol 12: 281, 1992","journal-title":"J Neurooncol"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00172459","volume":"12","author":"RE Merchant","year":"1992","unstructured":"Merchant RE, Davis D, Young HF: Immunotherapy for recurrent primary CNS malignancy using recombinant IL-2 plus systemic Roferon-A (Abstract). J Neurooncol 12: 267, 1992","journal-title":"J Neurooncol"},{"key":"CR66","first-page":"1123","volume":"52","author":"J List","year":"1992","unstructured":"List J, Moser RP, Steuer Met al.: Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor-alpha, interleukin 1-beta, interleukin 6, gamma-interferon, and soluble interleukin-2 receptor (Mr 55,000 protein). Cancer Res 52: 1123?1128, 1992","journal-title":"Cancer Res"},{"key":"CR67","first-page":"269","volume":"12","author":"Y Sawamura","year":"1992","unstructured":"Sawamura Y, Tada M, Sakuma Set al.: Intracranial administration of TNF-? elicits multiple immune responses in the central nervous system bearing malignant glioma (Abstract). J Neurooncol 12: 269, 1992","journal-title":"J Neurooncol"},{"key":"CR68","first-page":"251","volume":"12","author":"DD Bigner","year":"1992","unstructured":"Bigner DD, Wong A, Vogelstein Bet al.: Highly specific polyclonal and monoclonal antibodies against epidermal growth factor receptor mutant proteins of malignant astrocytic gliomas (MAG) (Abstract). J Neurooncol 12: 251, 1992","journal-title":"J Neurooncol"},{"key":"CR69","first-page":"251","volume":"12","author":"P Fredman","year":"1992","unstructured":"Fredman P, Wikstrand CJ, Svennerholm Let al.: Epitope specificity of monoclonal antibodies to glioma associated gangliosides and the quantitative measurement of these antigens in normal brain and brain tumors (Abstract). J Neurooncol 12: 251, 1992","journal-title":"J Neurooncol"},{"key":"CR70","first-page":"251","volume":"12","author":"CJ Wikstrand","year":"1992","unstructured":"Wikstrand CJ, Fredman P, Svennerholm Let al.: Expression of gangliosides GM2, GD2, GD3, 3?-isoLM1, and 3?,6?isoLD1 in CNS malignancies as defined by epitope-characterized monoclonal antibodies (Mabs) (Abstract). J Neurooncol 12: 251, 1992","journal-title":"J Neurooncol"},{"key":"CR71","first-page":"251","volume":"12","author":"MR Zalutsky","year":"1992","unstructured":"Zalutsky MR, Garg PK, Archer GEet al.: Therapeutic efficacy of anti-tenascin antibody 81C6 labeled with I-131 and AT-211 (Abstract). J Neurooncol 12: 251, 1992","journal-title":"J Neurooncol"},{"key":"CR72","first-page":"278","volume":"12","author":"HE Fuchs","year":"1992","unstructured":"Fuchs HE, Archer GE, Schuster JMet al.: A nude rat model of neoplastic meningitis for evaluation of intrathecal chemotherapy and monoclonal antibody (MAb)-based radiotherapy (Abstract). J Neurooncol 12: 278, 1992","journal-title":"J Neurooncol"},{"key":"CR73","first-page":"252","volume":"12","author":"RP Moseley","year":"1992","unstructured":"Moseley RP, Lashford LS, Coakham HBet al.: Intrathecal radioimmunoconjugate therapy for neoplastic meningitis (Abstract). J Neurooncol 12: 252, 1992","journal-title":"J Neurooncol"},{"key":"CR74","first-page":"268","volume":"12","author":"V Papanastassiou","year":"1992","unstructured":"Papanastassiou V, Tzanis S, Pizer Bet al.: Targeted radiation therapy for malignant glioma (Abstract). J Neurooncol 12: 268, 1992","journal-title":"J Neurooncol"},{"key":"CR75","first-page":"243","volume":"34","author":"LW Brady","year":"1990","unstructured":"Brady LW, Markoe AM, Woo DVet al.: Iodine-125 labeled anti-epidermal growth factor receptor-425 in the treatment of malignant astrocytomas. J Neurosurg Sci 34: 243?249, 1990","journal-title":"J Neurosurg Sci"},{"key":"CR76","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/bjc.1990.345","volume":"62","author":"RP Moseley","year":"1990","unstructured":"Moseley RP, Davies AG, Richardson RBet al.: Intrathecal administration of131I-labelled monoclonal antibody as a treatment for neoplastic meningitis. Br J Cancer 62: 637?642, 1990","journal-title":"Br J Cancer"},{"key":"CR77","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijc.2910510103","volume":"51","author":"P Riva","year":"1992","unstructured":"Riva P, Arista A, Sturiale Cet al.: Treatment of intracranial human glioblastoma by direct intratumoral administration of131I-labelled anti-tenascin monoclonal antibody BC-2. Int J Cancer 51: 7?13, 1992","journal-title":"Int J Cancer"},{"key":"CR78","first-page":"263","volume":"32","author":"AL Yu","year":"1991","unstructured":"Yu AL, Reisfeld RA, Gillies SD: Immune response to monoclonal anti-GD2 antibody therapy (Abstract). Proc Am Assoc Cancer Res 32: 263, 1991","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR79","first-page":"5461","volume":"51","author":"MB Khazaeli","year":"1991","unstructured":"Khazaeli MB, Saleh MN, Liu TPet al.: Pharmacokinetics and immune response of 131-I-chimeric mouse\/human B72.3 (human gamma-4) monoclonal antibody in humans. Cancer Res 51: 5461?5466, 1991","journal-title":"Cancer Res"},{"key":"CR80","first-page":"39A","volume":"4","author":"T Baker","year":"1991","unstructured":"Baker T, Begent R, Divgi Met al.: Characterization of the antibody response in patients undergoing radiotherapy with chimeric B72.3 (Abstract). Antibody Immunoconjugates Radiopharmaceuticals 4: 39A, 1991","journal-title":"Antibody Immunoconjugates Radiopharmaceuticals"},{"key":"CR81","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1073\/pnas.86.11.4220","volume":"88","author":"A LoBuglio","year":"1989","unstructured":"LoBuglio A, Wheeler R, Trang Jet al.: Mouse\/human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Sci USA 88: 4220?4224, 1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR82","first-page":"1162","volume":"32","author":"R Meredith","year":"1991","unstructured":"Meredith R, LoBuglio A, Plott Wet al.: Pharmacokinetics, immune response, and biodistribution of 121-I-labeled chimeric mouse\/human IgG1, kappa 17-1A monoclonal antibody. J Nucl Med 32: 1162?1168, 1991","journal-title":"J Nucl Med"},{"key":"CR83","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00005072-198805000-00001","volume":"47","author":"SH Bigner","year":"1988","unstructured":"Bigner SH, Burger PC, Wong Net al.: Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J Neuropathol Exp Neurol 47: 191?205, 1988","journal-title":"J Neuropathol Exp Neurol"},{"key":"CR84","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1073\/pnas.84.19.6899","volume":"84","author":"N Wong","year":"1987","unstructured":"Wong N, Bigner SG, Bigner DDet al.: Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84: 6899?6903, 1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR85","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1073\/pnas.87.11.4207","volume":"87","author":"PA Humphrey","year":"1990","unstructured":"Humphrey PA, Wong N, Vogelstein Bet al.: Anti-synthetic peptide antibody reacting at the fission junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc Natl Acad Sci USA 87: 4207?4211, 1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR86","first-page":"2711","volume":"48","author":"LT Maiden","year":"1988","unstructured":"Maiden LT, Novak U, Kaye AKet al.: Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme. Cancer Res 48: 2711?2714, 1988","journal-title":"Cancer Res"},{"key":"CR87","first-page":"5433","volume":"48","author":"PA Steck","year":"1988","unstructured":"Steck PA, Lee P, Hung MCet al.: Expression of an altered epidermal growth factor receptor by cultured human glioblastoma cell. Cancer Res 48: 5433?5439, 1988","journal-title":"Cancer Res"},{"key":"CR88","first-page":"51","volume":"32","author":"WKA Yung","year":"1991","unstructured":"Yung WKA, Bruner JM, Steck PA: High molecular weight TGF-a in human gliomas (Abstract). Proc Am Assoc Cancer Res 32: 51, 1991","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR89","first-page":"45","volume":"31","author":"WKA Yung","year":"1990","unstructured":"Yung WKA, Taylor S, Kim Yet al.: Expression and biological activity of transforming growth factor-alpha (TGF-?) in human glioma (Abstract). Proc Am Assoc Cancer Res 31: 45, 1990","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR90","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3727\/095535490820874416","volume":"2","author":"WKA Yung","year":"1990","unstructured":"Yung WKA, Zhang X, Steck PAet al.: Differential amplification of the TGF-alpha gene in human gliomas. Cancer Commun 2: 201?206, 1990","journal-title":"Cancer Commun"},{"key":"CR91","first-page":"4953","volume":"47","author":"M Nister","year":"1987","unstructured":"Nister M, Wedell B, Betsholtz Cet al.: Evidence for progressional changes in the human malignant glioma line U-343 MGa: analysis of karyotype and expression of genes encoding the subunit chains of platelet-derived growth factor. Cancer Res 47: 4953?4960, 1987","journal-title":"Cancer Res"},{"key":"CR92","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1227\/00006123-199102000-00007","volume":"28","author":"T Mapstone","year":"1991","unstructured":"Mapstone T, McMichael M, Goldthwait D: Expression of platelet-derived growth factors, transforming growth factors, and ros gene in a variety of primary human brain tumors. Neurosurgery 28: 216?222, 1991","journal-title":"Neurosurgery"},{"key":"CR93","first-page":"3910","volume":"48","author":"M Nister","year":"1988","unstructured":"Nister M, Libermann TA, Petsholtz Cet al.: Expression of messenger RNAs for platelet-derived growth factor and transformed growth factor-? and their receptors in human malignant glioma cell lines. Cancer Res 48: 3910?3918, 1988","journal-title":"Cancer Res"},{"key":"CR94","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/j.1460-2075.1987.tb02410.x","volume":"6","author":"TA Libermann","year":"1987","unstructured":"Libermann TA, Friesel R, Lyall PMet al.: An angiogenic growth factor is expressed in human glioma cells. EMBO J 6: 1627?1632, 1987","journal-title":"EMBO J"},{"key":"CR95","first-page":"2524","volume":"50","author":"RS Morrison","year":"1990","unstructured":"Morrison RS, Gross JL, Herlin WFet al.: Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. Cancer Res 50: 2524?2529, 1990","journal-title":"Cancer Res"},{"key":"CR96","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3171\/jns.1988.68.6.0920","volume":"68","author":"WC Clark","year":"1988","unstructured":"Clark WC, Bressler J: Transforming growth factor-?-like activity in tumors of the central nervous system. J Neurosurg 68: 920?924, 1988","journal-title":"J Neurosurg"},{"key":"CR97","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/B978-0-12-432014-7.50008-5","volume":"14","author":"A Fontana","year":"1987","unstructured":"Fontana A, Bodmer S, Frei K: Immunoregulatory factors secreted by astrocytes and glioblastoma cells. Lymphokines 14: 91?121, 1987","journal-title":"Lymphokines"},{"key":"CR98","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijc.2910490124","volume":"49","author":"MT Jennings","year":"1991","unstructured":"Jennings MT, Maciunas RJ, Carver Ret al.: TGF-?1 and TGF-?2 are potential growth regulators for low-grade and malignant gliomasin vitro: evidence in support of an autocrine hypothesis. Int J Cancer 49: 129?139, 1991","journal-title":"Int J Cancer"},{"key":"CR99","first-page":"388","volume":"33","author":"PA Steck","year":"1992","unstructured":"Steck PA, Hadi A, Pershouse MAet al.: Cellular and molecular consequences of re-insertion of chromosome 10 into human glioblastoma (Abstract). Proc Am Assoc Cancer Res 33: 388, 1992","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR100","first-page":"256","volume":"12","author":"H Saya","year":"1992","unstructured":"Saya H, Nishi T, Lee PSYet al.: Alternative approaches of the neurofibromatosis type l (NF1) gene transcript during neuronal differentiation. J Neurooncol 12: 256, 1992","journal-title":"J Neurooncol"},{"key":"CR101","first-page":"255","volume":"12","author":"B Westermark","year":"1992","unstructured":"Westermark B: Platelet-derived growth factor as a mitogen for normal and malignant cells in the central nervous system (Abstract). J Neurooncol 12: 255, 1992","journal-title":"J Neurooncol"},{"key":"CR102","first-page":"247","volume":"12","author":"PC Burger","year":"1992","unstructured":"Burger PC: Pathological and autopsy studies of glioblastoma multiforme (Abstract). J Neurooncol 12: 247, 1992","journal-title":"J Neurooncol"},{"key":"CR103","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3171\/jns.1983.58.2.0159","volume":"58","author":"PC Burger","year":"1983","unstructured":"Burger PC, Dubois PJ, Schold SC Jr, Smith KR Jr, Odom GL, Crafts DC, Giangaspero F: Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58: 159?169, 1983","journal-title":"J Neurosurg"},{"key":"CR104","first-page":"270","volume":"12","author":"D Schiffer","year":"1992","unstructured":"Schiffer D, Bertolotto A, Giordana MTet al.: Spreading and invasion patterns of malignant gliomas (Abstract). J Neurooncol 12: 270, 1992","journal-title":"J Neurooncol"},{"key":"CR105","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0025-6196(12)65470-6","volume":"62","author":"PJ Kelly","year":"1987","unstructured":"Kelly PJ, Daumas-Duport C, Scheithauer BWet al.: Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 62: 450?459, 1987","journal-title":"Mayo Clin Proc"},{"key":"CR106","first-page":"383A","volume":"76","author":"ML Rosenblum","year":"1992","unstructured":"Rosenblum ML, Eisenberg AD, Norman D: Brain tumor invasion: clinical patterns of malignant astrocytoma spread (Abstract). J Neurosurg 76: 383A, 1992","journal-title":"J Neurosurg"},{"key":"CR107","first-page":"247","volume":"12","author":"CB Wilson","year":"1992","unstructured":"Wilson CB: Glioblastoma ? a local disease (Abstract). J Neurooncol 12: 247, 1992","journal-title":"J Neurooncol"},{"key":"CR108","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.30.9.907","volume":"30","author":"FH Hochberg","year":"1980","unstructured":"Hochberg FH, Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology 30: 907?911, 1980","journal-title":"Neurology"},{"key":"CR109","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0360-3016(90)90106-T","volume":"18","author":"V Massey","year":"1990","unstructured":"Massey V, Wallner KE: Patterns of second recurrence of malignant astrocytomas. Int J Radiat Oncol Biol Phys 18: 395?398, 1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR110","first-page":"248","volume":"12","author":"JS Loeffler","year":"1992","unstructured":"Loeffler JS, Alexander E III, Black PMet al.: The results of radiosurgery used in the management of newly diagnosed and recurrent malignant gliomas (Abstract). J Neurooncol 12: 248, 1992","journal-title":"J Neurooncol"},{"key":"CR111","first-page":"257","volume":"12","author":"JT Kemshead","year":"1992","unstructured":"Kemshead JT: Targeted approaches to developing highly specific reagents to tumours arising from the neuroectoderm (Abstract). J Neurooncol 12: 257, 1992","journal-title":"J Neurooncol"},{"key":"CR112","first-page":"257","volume":"12","author":"RH Kramer","year":"1992","unstructured":"Kramer RH, Ramos D, Amar Aet al.: Invasive tumor cells use multiple integrin receptors during interaction with the extracellular matrix (Abstract). J Neurooncol 12: 257, 1992","journal-title":"J Neurooncol"},{"key":"CR113","first-page":"257","volume":"12","author":"JH McKerrow","year":"1992","unstructured":"McKerrow JH, Brown M, Wall Jet al.: The role of proteases in brain tumor invasion (Abstract). J Neurooncol 12: 257, 1992","journal-title":"J Neurooncol"},{"issue":"Suppl","key":"CR114","first-page":"S5","volume":"7","author":"ME Berens","year":"1989","unstructured":"Berens ME, Spencer DR, Rosenblum ML: Glioma-derived factors linked to invasion (Abstract). J Neurooncol 7 (Suppl): S5, 1989","journal-title":"J Neurooncol"},{"key":"CR115","first-page":"279","volume":"12","author":"RC Janzer","year":"1992","unstructured":"Janzer RC: Blood-brain barrier breakdown in malignant gliomas may be mediated by the extracellular matrix secreted by tumor cells (Abstract). J Neurooncol 12: 279, 1992","journal-title":"J Neurooncol"},{"key":"CR116","first-page":"273","volume":"12","author":"ME Berens","year":"1992","unstructured":"Berens ME, Rief MD, Stachowiak MK: Novel epidermal growth factor receptor processing in human malignant glioma cells (Abstract). J Neurooncol 12: 273, 1992","journal-title":"J Neurooncol"},{"key":"CR117","first-page":"258","volume":"12","author":"OD Laerum","year":"1992","unstructured":"Laerum OD, Pedersen P-H, Lund-Johansen Met al.: Growth factor and invasiveness of malignant gliomas (Abstract). J Neurooncol 12: 258, 1992","journal-title":"J Neurooncol"},{"key":"CR118","first-page":"283","volume":"12","author":"P-H Pedersen","year":"1992","unstructured":"Pedersen P-H, Lund-Johansen M, Engebraaten Oet al.: Heterogenous response to growth factors (EGF, PDGF, TGF-?, IL-2) on glioma spheroid growth, migration and invasion (Abstract). J Neurooncol 12: 283, 1992","journal-title":"J Neurooncol"},{"key":"CR119","first-page":"260","volume":"12","author":"LA Liotta","year":"1992","unstructured":"Liotta LA: Negative regulation of cancer invasion (Abstract). J Neurooncol 12: 260, 1992","journal-title":"J Neurooncol"},{"key":"CR120","first-page":"277","volume":"12","author":"O Engebraaten","year":"1992","unstructured":"Engebraaten O, Bjerkvig R, M\u00f8rkve Oet al.: GM2 ganglioside and p53 expression is linked to glioblastoma cell invasiveness (Abstract). J Neurooncol 12: 277, 1992","journal-title":"J Neurooncol"},{"key":"CR121","first-page":"272","volume":"12","author":"ML Rosenblum","year":"1992","unstructured":"Rosenblum ML, Amar AP, Stowring LEet al.: Development ofin vitro andin vivo models to study human brain tumor invasion (Abstract). J Neurooncol 12: 272, 1992","journal-title":"J Neurooncol"},{"key":"CR122","first-page":"3239","volume":"47","author":"A Albini","year":"1987","unstructured":"Albini A, Iwamoto Y, Kleinman HKet al.: A rapidin vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239?3245, 1987","journal-title":"Cancer Res"},{"key":"CR123","first-page":"6933","volume":"48","author":"LJ Erkell","year":"1988","unstructured":"Erkell LJ, Schirrmacher V: Quantitativein vitro assay for tumor cell invasion. Cancer Res 48: 6933?6937, 1988","journal-title":"Cancer Res"},{"key":"CR124","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/bi00350a005","volume":"25","author":"HK Kleinman","year":"1986","unstructured":"Kleinman HK, McGarvey ML, Hassell JRet al.: Basement membrane complexes with biological activity. Biochemistry 25: 312?318, 1986","journal-title":"Biochemistry"},{"key":"CR125","first-page":"4071","volume":"46","author":"R Bjerkvig","year":"1986","unstructured":"Bjerkvig R, Laerum OD, Mella O: Glioma cell interactions with fetal rat brain aggregatesin vitro and with brain tissuein vivo. Cancer Res 46: 4071?4079, 1986","journal-title":"Cancer Res"},{"key":"CR126","first-page":"258","volume":"12","author":"R Bjerkvig","year":"1992","unstructured":"Bjerkvig R, Pedersen PH, Terzis AJAet al.: Tissue specific invasion of brain tumors (Abstract). J Neurooncol 12: 258, 1992","journal-title":"J Neurooncol"},{"key":"CR127","first-page":"277","volume":"12","author":"O Engebraaten","year":"1992","unstructured":"Engebraaten O, Bjerkvig R, Laerum ODet al.: Alkyl-lysophospholipid reduces human glioblastoma cell invasion (Abstract). J Neurooncol 12: 277, 1992","journal-title":"J Neurooncol"},{"key":"CR128","first-page":"286","volume":"12","author":"AJA Terzis","year":"1992","unstructured":"Terzis AJA, Bjerkvig R, Arnold Het al.: Interaction between human medulloblastoma and fetal rat brain aggregatesin vitro (Abstract). J Neurooncol 12: 286, 1992","journal-title":"J Neurooncol"},{"key":"CR129","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1083\/jcb.107.6.2281","volume":"107","author":"PA Paganetti","year":"1988","unstructured":"Paganetti PA, Caroni P, Schwab ME: Glioblastoma infiltration into central nervous system tissuein vitro: involvement of a metalloprotease. J Cell Biol 107: 2281?2291, 1988","journal-title":"J Cell Biol"},{"key":"CR130","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1227\/00006123-199004000-00010","volume":"26","author":"JJ Bernstein","year":"1992","unstructured":"Bernstein JJ, Goldberg WJ, Laws ER Jret al.: C6 glioma cell invasion and migration of rat brain after neural homografting ultrastructure. Neurosurgery 26: 622?628, 1992","journal-title":"Neurosurgery"},{"key":"CR131","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF02427829","volume":"9","author":"O Mella","year":"1990","unstructured":"Mella O, Bjerkvig R, Schem BCet al.: A cerebral glioma model for experimental therapy andin vivo invasion studies in syngeneic BD IX rats. J Neurooncol 9: 93?104, 1990","journal-title":"J Neurooncol"},{"key":"CR132","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jnr.490220205","volume":"22","author":"JJ Bernstein","year":"1989","unstructured":"Bernstein JJ, Goldberg WJ, Laws ER Jret al.: Human malignant astrocytoma xenografts migrate in rat brain: a model for central nervous system cancer research. J Neurosci Res 22: 134?145, 1989","journal-title":"J Neurosci Res"},{"key":"CR133","first-page":"2322","volume":"50","author":"G Apodaca","year":"1990","unstructured":"Apodaca G, Rutka JT, Bouhana Ket al.: Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 50: 2322?2329, 1990","journal-title":"Cancer Res"},{"key":"CR134","first-page":"5054s","volume":"51","author":"LA Liotta","year":"1991","unstructured":"Liotta LA, Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054s-5059s, 1991","journal-title":"Cancer Res"},{"key":"CR135","volume-title":"Radiation Injury to the Nervous System","author":"PH Gutin","year":"1991","unstructured":"Gutin PH, Leibel SA, Sheline GE: Radiation Injury to the Nervous System. Raven Press, New York, 1991"},{"key":"CR136","first-page":"91","volume-title":"Radiation Injury to the Nervous System","author":"AJ Kogel van der","year":"1991","unstructured":"van der Kogel AJ: Central nervous system radiation injury in small animal models. In: Gutin PH, Leibel SA, Sheline GE (eds) Radiation Injury to the Nervous System, Raven Press, New York, 91?111, 1991"},{"key":"CR137","series-title":"Frontiers of Radiation Therapy and Oncology series","volume-title":"Proceedings of the 23rd Annual San Francisco Cancer Symposium, San Francisco, CA, March 4?5,1988","author":"JM Vaeth","year":"1989","unstructured":"Vaeth JM, Meyer JL: Radiation Tolerance of Normal Tissues. Frontiers of Radiation Therapy and Oncology series. Proceedings of the 23rd Annual San Francisco Cancer Symposium, San Francisco, CA, March 4?5,1988, Vol 23, Karger, Basel, 1989"},{"key":"CR138","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/09553009014552211","volume":"58","author":"RWM Maazen van der","year":"1990","unstructured":"van der Maazen RWM, Verhagen I, van der Kogel AJ: Anin vitro clonogenic assay to assess radiation damage in rat CNS glial progenitor cells. Int J Radiat Biol 58: 835?844, 1990","journal-title":"Int J Radiat Biol"},{"key":"CR139","first-page":"260","volume":"12","author":"AJ Kogel van der","year":"1992","unstructured":"van der Kogel AJ: Radiation tolerance of the CNS:in vivo andin vitro studies (Abstract). J Neurooncol 12: 260, 1992","journal-title":"J Neurooncol"},{"key":"CR140","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3171\/jns.1991.74.4.0625","volume":"74","author":"N Yamaguchi","year":"1991","unstructured":"Yamaguchi N, Yamashima T, Yamashita J: A histological and flow cytometric study of dog brain endothelial cell injuries in delayed radiation necrosis. J Neurosurg 74: 625?632, 1991","journal-title":"J Neurosurg"},{"key":"CR141","first-page":"288","volume":"12","author":"J Yamashita","year":"1992","unstructured":"Yamashita J, Yamaguchi N, Yamashima T: Endothelial injuries in delayed radiation necrosis of the brain in dogs (Abstract). J Neurooncol 12: 288, 1992","journal-title":"J Neurooncol"},{"key":"CR142","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0006-291X(83)80247-2","volume":"55","author":"J Koenig","year":"1983","unstructured":"Koenig J, Goldstone AD, Lu CY: Blood-brain barrier breakdown in brain edema following cold injury is mediated by microvascular polyamines. Biochem Biophys Res Commun 55: 1039?1048, 1983","journal-title":"Biochem Biophys Res Commun"},{"key":"CR143","first-page":"260","volume":"12","author":"GT Gobbel","year":"1992","unstructured":"Gobbel GT, Fike JR: Cerebrovascular response of dog brain to focal irradiation and its modification by ?-difluoromethylornithine (Abstract). J Neurooncol 12: 260, 1992","journal-title":"J Neurooncol"},{"key":"CR144","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2307\/3578054","volume":"128","author":"GT Gobbel","year":"1991","unstructured":"Gobbel GT, Marton LJ, Lamborn Ket al.: Modification of radiation-induced brain injury by ?-difluoromethylornithine. Radiat Res 128: 306?315, 1991","journal-title":"Radiat Res"},{"key":"CR145","first-page":"274","volume":"12","author":"M Ernstein","year":"1992","unstructured":"BErnstein M, Glen J, Parsons Ket al.: Modification of brachytherapy by acetylsalicylic acid (ASA) in a rat model (Abstract). J Neurooncol 12: 274, 1992","journal-title":"J Neurooncol"},{"key":"CR146","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1227\/00006123-198906000-00003","volume":"24","author":"M Prados","year":"1989","unstructured":"Prados M, Rodriguez L, Chamberlain Met al.: Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and alpha-difluoromethylornithine. Neurosurgery 24: 806?809, 1989","journal-title":"Neurosurgery"},{"key":"CR147","first-page":"459","volume":"71","author":"VA Levin","year":"1987","unstructured":"Levin VA, Chamberlain MC, Prados MDet al.: Phase I?II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors. Cancer Treat Rep 71: 459?464, 1987","journal-title":"Cancer Treat Rep"},{"key":"CR148","first-page":"273","volume":"12","author":"H Basu","year":"1992","unstructured":"Basu H, Pellarin M, Feuerstein BG: Interaction of N1,N19-bisethyl)amino-5,10,15-triazanonadecane (BE-4444) with DNA and its effects on growth, survival and polyamine levels (Abstract). J Neurooncol 12: 273, 1992","journal-title":"J Neurooncol"},{"key":"CR149","first-page":"2424","volume":"52","author":"RJ Bernacki","year":"1992","unstructured":"Bernacki RJ, Bergeron RJ, Porter CW: Antitumor activity of N,N?-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts. Cancer Res 52: 2424?2430, 1992","journal-title":"Cancer Res"},{"key":"CR150","unstructured":"Basu HS, Pellarin M, Feuerstein BG, Deen DF, Marton LJ: Effects of the polyamine analogs BE-3-7-3, 3-8-3, and BE-3-8-3 on human brain tumor cell growth and survival. Anticancer Res (In press)"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01057041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01057041\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01057041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T22:15:51Z","timestamp":1682979351000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01057041"}},"subtitle":["Organ System Program, National Cancer Institute"],"short-title":[],"issued":{"date-parts":[[1993]]},"references-count":150,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993]]}},"alternative-id":["BF01057041"],"URL":"https:\/\/doi.org\/10.1007\/bf01057041","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993]]}}}